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Abstract 
 
 Ongoing evaluation of current practice and incorporation of evidence based research into 
guidelines and protocols is a requirement for the provision of high quality, cost efficient care.  
Despite some literature describing observational data, midline catheters (MCs) are not an 
appropriate vascular access device for Newborn Intensive Care Unit (NICU) patients due to 
insufficient high level evidence demonstrating safety and efficacy.  In addition, national 
guidelines for MC use in neonatal and infant patients lacks sufficient information for safe and 
effective use of MCs.   
  The results of this small, online survey indicate that while some neonatal nurses and 
Nurse Practitioners report the use of MC use in the NICU, there is a wide range of practice 
pertaining to MC unit-specific protocols, competencies, success with placement, and clinician 
agreement of appropriate use for this vascular access device (VAD).  Multicenter, randomized 
control trials are needed to evaluate current MC practice in the NICU, and institutions must 
incorporates current, evidence based practice into policies, procedures, and guidelines.   
 
 
 
Keywords:  catheters, infant, midline, neonatal, and premature

Introduction 
 Prolonged intravenous (IV) access is frequently required for critically ill and premature 
infants in the Newborn Intensive Care Unit (NICU) to provide nutritional and pharmacologic 
support.  High level evidence must guide clinical decision making and management of all 
vascular access devices (VADs), including peripheral intravenous (PIV) catheters, peripherally 
inserted central catheters (PICCs), and midline catheters (MCs).  Institutional and national PICC 
guidelines include basic MC information, but VAD decision making may be based on clinician 
preference rather than clinical evidence due to a lack of evidence based research in the form of 
high quality studies (National Association of Neonatal Nurses PICC Guidelines, 2007).  When 
deciding upon which VADs are appropriate for individual patients, the NICU team may have 
difficulty reaching consensus based on professional experience and/or lack of knowledge 
regarding evidence based recommendations.     
 Prospective observational studies have demonstrated that when compared to peripheral 
IVs, MCs result in fewer cannulations, longer dwell times, less extravasation, and improved cost 
efficiency (Alexandrou et al., 2011; Anderson, 2004; Dawson, 2002; Frey & Pettit, 2010; Goetz, 
Miller, Wagener, & Muder 1998.; Griffiths, 2007; Leick-Rude and Haney, 2006; Lesser, 
Chhabra, Brion, & Suresh, 1996; National Association of Neonatal Nurses, 2007; Rosenthal, 
2008; Victor, 1997; and Wyckoff, 1999).  When compared to PICCs, prospective observational 
studies found MCs to have increased rates of chemical and mechanical phlebitis and lower rates 
of infection (Alexandrou et al., 2011; Colacchio, Deng, Northrup, & Bizzarro, 2012; Goetz, et 
al., 1998; Leick-Rude and Haney, 2006; Lesser et al., 1996; NANN, 2007; Victor, 1997).  
Several authors have reported that MCs may also improve cost efficiency by minimizing the time 
and equipment spent on repeated PIV cannulations (Alexandrou, et al., 2011; Anderson, 2004; 
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Griffiths, 2007; and Rosenthal, 2008).  Dawson (2002) found that the potential for cost savings 
may result from fewer central line infections and shorter length of hospital stay, less nursing time 
required, and lower pharmacological costs.  Unfortunately, there is a lack of evidence in the form 
of randomized control trials or systematic reviews, to support the observational findings 
suggesting that MCs may be a safe and reliable VAD for NICU patients.   
Problem  
 As clinicians strive to improve health care in the information age of the 21st century, it is 
crucial that clinicians not only recognize, but accept and integrate evidence-based practice (EBP) 
into patient care on a daily basis.  Rapidly advancing technology, an aging population, and 
increasingly complex medical diagnoses, challenge health care professionals to maintain a 
current knowledge base and to provide care that is proven to be effective, safe, and cost efficient.  
Integration of EBP is a steadfast requirement for clinical decision-making and for providing 
standardized care for patients across all settings.  According to Grol and Grimshaw (2005), 
approximately 10,000 new randomized trials are added to MEDLINE every year.  It is difficult 
for clinicians to synthesize the continual high volume of published evidence, and even more 
challenging to incorporate changes in clinical practice into daily patient management.  As a 
result, there is a known gap between clinical evidence and clinical practice across disciplines.  
Prasad et al. (2013) found that of 35 studies testing standard of care, 46% contradicted current 
practice.  In fact, studies suggest that 30-40% of patients do not receive care according to current 
scientific evidence (Grol & Grimhaw, 2005).   
 Another barrier to implementing current clinical evidence into daily clinical practice may 
reside in the dependence on clinical practice guidelines which are lacking in evidence based 
recommendations.  Clinical practice guidelines are typically developed by professional 
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organizations and provide a foundation for state and institutional protocols.  Unfortunately, 
guidelines and protocols may not be based on the most current evidence, and there is increasing 
concern about the quality of guidelines produced by national organizations (Cosgrove, Bursztajn, 
Erlich, Wheeler, & Shaughnessy, 2012; Singleton & Levin, 2008).  As such, the quality of 
clinical practice guidelines may be variable and may not incorporate evidence based research 
into recommendations for standard of care. (Brouwers et al., 2010).   
 Silverman (2004) adeptly described the history and evolution of oxygen use in premature 
infants, beginning in the 1940s.  The lack of evidence for the use of oxygen necessitated multiple 
attempts to guide the use of this unfamiliar “drug” and address the subsequent epidemic of 
blindness that followed.  Guidelines for the use of oxygen in premature infants continues to 
evolve and elicit ongoing research today.   Makic, Martin, Burns, Philbrick, & Rauen (2013) 
discuss the recognized problem of care being guided by tradition rather than current evidence.  
Implementation of a change in clinical practice guidelines may be another obstacle in the effort 
to improve patient care based on current high level evidence.  In order to successfully implement 
a change in guidelines and protocols, it is important to acknowledge the potential for doubt about 
the need for innovation (van Achterberg, Schoonhoven, & Grol, 2008). 
Solution 
 According to Raines (2013), EBP is “the conscientious, explicit, and judicious use of 
current research findings.”  It is the “integration of individual clinical expertise with the best 
available external clinical evidence from systematic research” (p. 203).  The importance of EBP 
is recognized by health care companies, government agencies, and national professional 
organizations (Makic, et al., 2013).  When the highest quality of clinical research is completed, it 
then becomes the responsibility of  multidisciplinary teams to synthesize the evidence and 
 4 
incorporate the findings into clinical practice guidelines and protocols. The AGREE II tool was 
developed to “assess the quality of guidelines; provide a methodological strategy for the 
development of guidelines; and to inform what information and how information ought to be 
reported in guidelines” (Brouwers et al., 2010, p. 1).   
 The solution, then, lies in scrutinizing national, state, and institutional guidelines and 
protocols for inclusion of the most current and evidence based research.  According to the 
Institute of Medicine (2011), clinical practice guidelines should provide an evaluation of current 
evidence based research in such a way as to enable clinicians to provide the highest quality of 
standardized care.  If a change in clinical practice if indicated, the process for change must be 
implemented in such a way that allows for an understanding of the importance and necessity of 
EBP, and provides an opportunity for clinicians to embrace the need for innovation. 
Project Purpose 
 According to the National Association of Neonatal Nurses (NANN) PICC Guidelines, 
establishing uninterrupted therapy, preserving the peripheral vasculature, cost efficiency, and 
patient comfort should be taken into consideration when deciding which VAD is most 
appropriate (2007).  Limited data is available on MCs in the NICU and all available research is 
strictly observational (Anderson, 2004; BeVier & Rice, 1994; Goetz, et al., 1998; and Griffiths, 
2007; Leick-Rude & Haney, 2006; Lesser et al., 1996; Mermel, Parenteau, & Tow, 1995; 
Wyckoff, 1999).   
 Ongoing evaluation of current practice and incorporation of current, evidence based 
research into guidelines and protocols is a requirement for the provision of high quality, cost 
efficient care.  The use of MCs in the NICU is not supported by high level evidence.  The project 
purpose is to provide for a diffusion of knowledge, via scholarly review and clinician education, 
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in such a way as to encourage understanding and support for the discontinuation of MC use in 
NICU patients, and subsequent change in an institutional protocol.   
 Rogers’ theory for diffusion (2003) is applicable in the effort to implement change as the 
four main elements for changing MC use will involve diffusion, innovation, communication, and 
the social system of the NICU.  Furthermore, as described by van Achterberg et al. (2008), 
activities to guide change may be involuntary, such as official changes to guidelines and 
protocols; or voluntary, such as when educational efforts and clinical support result in extrinsic 
and intrinsic motivation.  The project will incorporate Rogers’ theory for diffusion while 
encouraging multidisciplinary motivation for what will ultimately be a change in clinical practice 
as MCs become discontinued as a viable VAD for use in NICU patients. 
 In accordance with the American Association of Colleges of Nursing Essentials of 
Doctoral Education for Advanced Practice (2006), several objectives for graduate learning 
outcomes are realized by a thorough review of the literature, evaluation of current policies and 
procedures, and analysis of current trends in clinical decision making regarding the use of MCs 
in the NICU.  Competent leadership skills are required to successfully institute a feasible and 
sustainable change in practice as a result of diffusion of knowledge based on a lack of high level 
evidence for the use of MCs in the NICU. 
Definition of Terms 
 Midline catheter (MC). The MC is a peripheral vascular access device with the tip 
terminating in the basilic, cephalic, or brachial vein (Infusion Nursing Society, 2011).  
According to Frey and Pettit (2010): 
 The midline catheter, composed of polyurethane or silicone, is longer than a peripheral 
 IV catheter and is intended for use in neonates and children who require therapy of 
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 intermediate duration.  The catheter is inserted into a peripheral vein in the antecubital  
 area and is advanced into the upper arm veins, but not past the axilla.  Other sites for 
 midline insertion include the leg (with the tip away from areas of flexion and below the 
 groin) and the scalp (with the tip located in the neck and above the thorax).  
 Neonate. A newborn infant, in the first 28 days of life (Dictionary.com). 
 Peripherally inserted central catheter (PICC). The NANN PICC Guidelines define a 
PICC as a “device inserted into a peripheral vein and threaded into the central venous 
circulation” (p. 6). 
 Peripherally inserted non-central catheter (PINCC). According to Colacchio, et al. 
(2012), PINCCs are intended to be centrally located as a PICC, but do not reach a central 
position during the procedure.  MCs are different from PINCCs as the catheters are shorter and 
they are not intended to be placed centrally. 
 Peripheral intravenous catheter (PIV). The tip of a PIV terminates in a peripheral vein. 
 Premature infant. An infant born at any date during pregnancy prior to the completion 
of 37 weeks gestation (Merenstein & Gardner, 1993). 
Summary   
 To date, there are no randomized control trials or systematic reviews examining the use 
of MCs in the neonatal population.  However, observational studies support the use of MCs for 
the infusion of IV fluids and medications in infants who meet criteria based on expected dwell 
time, infusate composition, and certain physiologic requirements.  Professional experience 
and/or lack of knowledge may result in disagreement among clinical providers in regard to VAD 
decision making in the neonatal population.   
Review of Literature 
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 A PICO (i.e. Population, Intervention, Comparison, and Outcome) question was used to 
guide the literature review (Melnyk, Fineout-Overholt, Stillwell, & Williamson, 2010). The 
PICO question is: In the NICU, how is the incidence of infection and extravasation associated 
with VADs affected by the implementation of a MC Protocol?  The population in this review is 
sick and premature neonates and infants in the NICU; the intervention is the development and 
implementation of an NICU MC Protocol; the comparison group is the group of infants who 
receive MCs based on protocol criteria; and the outcomes are the rates of PICC and MC related 
infection and extravasation after the MC Protocol is incorporated into the IV access algorithm.   
Data Sources and Search Process 
 The keywords utilized in the search included catheters, infant, midline, neonatal, and 
premature.  The databases utilized in the search were CINAHL, Cochrane Library, Joanna 
Briggs Institute, Ovid Medline, and Pubmed.  Twenty-six publications were identified by 
database and hand searches. Eleven publications remained after duplicates were removed.  Four 
publications were eliminated because they contained content about central lines (PICCs or 
umbilical lines) exclusively, and/or the VADs being reviewed were not clearly defined as central 
or midline.  In addition to journal articles, the hand search included the Infusion Nurses (INS) 
Society Position Paper on (1997), the INS Standards of Practice publication and textbook (2011), 
and the NANN PICC Guidelines (2007).  A total of 18 publications were included for the 
literature review (Figure 1).  See Appendix A for Tables 1, 2, and 3 which provide a synopsis of 
the literature review. 
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Figure 1. Flow diagram of publication selection process. Adapted from “Reprint - Preferred 
reporting items for systematic reviews and meta-analyses: The PRISMA statement,” by D. 
Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and The PRISMA Group, 2009, Physical Therapy, 
89(9).  
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Evaluation of Clinical Practice Guidelines 
 The original Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument 
was published in 2003 to assess the quality of clinical practice guidelines.  The AGREE II 
Instrument replaced the original AGREE Instrument in 2010.  In addition to the quality of 
guidelines, the AGREE II also assesses the “methodological rigor and transparency” of clinical 
guidelines development (Brouwers et al., 2010).  The AGREE II Instrument includes 23 items 
which are organized into six domains: scope and purpose, stakeholder involvement, rigor of 
development, clarity of presentation, applicability, and editorial independence.  The NANN 
PICC Guideline for Practice, 2nd Edition (2007) was evaluated by the AGREEII Instrument (see 
Appendix B). 
 Scope and practice.  The intent of the guidelines, as stated in the preface, is to support 
nursing practice and promote infant safety in regard to insertion and maintenance of PICCs in 
neonatal patients.  The content of the guidelines includes a section on Potential Insertion-Related 
Difficulties and a troubleshooting guide to address clinical issues.  Although the guideline is 
intended for infants, there is no mention of specific recommendations for gestational age, post-
conceptual age, or weight.  
 Stakeholder involvement.  The acknowledgments, state that BD Medical Systems 
provided an educational grant for the publication of the guideline.  The authors and reviewers are 
also acknowledged.  The target population perspective is addressed by the inclusion of a parent 
information guide in the appendix.  Target users of the guideline are nurses trained in neonatal 
PICC insertion and maintenance. 
 Rigor of development.  The guideline is most negligent in this domain as there is no 
mention of a systematic review of the literature or how evidence was selected for development of 
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the recommendations.  A thorough reference section is included.  The risks associated with PICC 
placement in the neonatal population are included in a section on Post-insertion Complications.  
The translation of evidence into practice recommendations is available in an appendix as Clinical 
Competencies.  A list of external nursing reviewers is included in the acknowledgment section. 
 Clarity of presentation.  Procedural guidelines for PICC placement are clear and 
specific.  Midline catheter procedure guidelines are not included.  VAD comparisons and 
infusate considerations are reviewed.  Due to limited data on recommended dwell times for 
midline catheters, and variations in diagnosis, vascular assessment, and therapeutic and 
nutritional needs among NICU patients, an algorithm of recommended VAD decision making is 
not included.   
 Applicability.  Other than a brief discussion of Food and Drug Administration reporting 
requirements for device malfunctions, there is no discussion of barriers, guideline utilizations, or 
quality indicators.  Educational competencies, vein anatomy figures, a trouble-shooting guide, 
and documentation tools are included in the guidelines.  Applicable cost-related issues are not 
included.  Measurements of guideline recommendation outcomes are not included. 
 Editorial independence.  The Acknowledgment section includes a statement declaring 
that although BD Medical provided a grant for the guideline development, they had no input into 
the content of the guideline.  The developing group does not appear to have competing interests. 
 Overall Guideline Assessment.  An evaluation of NANN’s PICC Guidelines for 
Practice with the AGREE II tool, resulted in a score of 39%, with the highest possible score 
being 100% (Appendix A).  The Rigor of Development and Applicability domains were scored 
the lowest.  This clinical guideline for practice is recommended for use with modifications. 
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Analysis 
 Historical perspective.  Midline catheters were first introduced in the adult population in 
the 1950s by Deseret Medical Corporation.  The device was inserted by an introducer needle and 
was used for surgical patients requiring at least seven days of IV therapy (Anderson, 2004; 
Griffiths, 2007).  The design of the midline catheter continued to evolve and a peel-away plastic 
introducer was developed in the 1980s.  In 1992, Moran described a new midline catheter being 
used in the neonatal population.  The Aquavene Catheter, manufactured by Landmark, did not 
entail an introducer or a guidewire, and was inserted by an over-the-needle design. At that time 
the Landmark catheter was felt to be advantageous, particularly for neonatal patients because the 
biocompatible polymer, Aquavene, reportedly softened to become flexible and expand in the 
vessel.  This feature demonstrated dwell times comparable to silicone catheters, but with less risk 
for infection.  The catheters were also felt to be less thrombogenic due to the hydrogel 
component (Alexandrou, et al., 2011; Goetz, et al.; Mermel, et al., 1995; Moran, 1992) . 
 Although more than 500,000 Landmark catheters had been sold by 1995, there was no 
published data available in which the catheters were cultured at the time of removal (Mermel et 
al., 1995).  This lack of data was the basis for a prospective study by Mermel et al. in 1995, 
which evaluated the risk for infection associated with the use of the Landmark catheter in 
hospitalized patients.  The findings confirmed a low risk for infections related to midline 
catheters, but it also became evident that the Landmark catheters had been associated with 
several life threatening adverse reactions.  The authors described the adverse reactions associated 
with catheter placement in three patients and also found several similar unpublished cases which 
had been reported to the FDA.  Based on concerns that the coating on the Landmark catheter was 
the cause of the adverse reactions, it was taken off the market in in 1997 (Anderson, 2004).  
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 Device.  MCs currently available for use in infants are composed of polyurethane or 
silicone as single or double lumen, and are available in 1.9-3.0 Fr., and in gauge sizes of 22-24 
(Frey & Pettit, 2010; Infusion Nurses Society, 2011).  
 Placement.   Alexandrou, et al. (2011) reported that MCs are not appropriate for adult 
patients with a history of thrombosis, hypercoagulopathy, medical conditions which impede 
venous flow from an extremity, or those with an arteriovenous fistula for dialysis.  Variables to 
consider when evaluating which VADs are appropriate for infants including gestational age, 
weight, presence of congenital anomalies, cardiorespiratory monitoring requirements, sepsis, 
current clinical condition and ability to tolerate the procedure,  anticipated type and duration of 
IV solutions and medications, previous history with VADs, and the expected duration of IV 
therapy (Moran, 1992; NANN, 2007). 
  Midline catheters are inserted into a peripheral vein in the antecubital fossa and 
advanced with the tip terminating in the basilic, cephalic, or brachial vein distal to the shoulder 
(Figure 2).  According to the Infusion Nurses Society (1997, 2011) additional sites for 
consideration in infants include the external jugular, axillary, long and short saphenous, 
temporal, and posterior auricular veins (Frey and Petit, 2010; Wyckoff, 1999).  In comparison to 
PICCs, the tip purposefully does not extend past the axillary vein or the inguinal fold (Colacchio 
et al., 2012). 
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Figure 2. The major veins that may be used for PICC placement in young infants. From National 
Association of Neonatal Nurses. (2007). Peripherally inserted central catheters: 
Guideline for practice (2nd ed.) (p. 13). Glenview, IL: National Association of Neonatal 
Nurses. Reprinted with permission. 
 MC placement does not require radiologic confirmation as the tip lies in a large, 
peripheral vessel (Alexandrou, et al., 2011; Goetz et al., 1998; Griffiths, 2007).   As a result of 
fewer X-rays with MC placement, Mermel et al. (1995) and Wyckoff (1999) reported reduced 
hospital costs.  The Intravenous Nurses Society 1997 Position Paper on Midline and 
Midclavicular Catheters recommended X-ray confirmation only in the following clinical 
situations:  
 difficulty with catheter advancement; pain or discomfort after catheter advancement; 
 inability to obtain free flowing blood return; inability to flush the catheter easily; the 
 guidewire is difficult to remove or is bent after removal; pain, discomfort, feelings of 
 fullness or coldness, or hearing gurgling sounds during flushing. (p. 177) 
Courtesy and © Becton, Dickinson and Company 
Reprinted with permission 
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 Dwell time.  There is a recognized lack of consistent recommendations in the literature 
regarding acceptable MC dwell times.  Lesser et al. (1996) enrolled nine infants less than 34 
weeks’ gestation and greater than five days of age if they were expected to require IV therapy for 
at least 10 days.  The average dwell time for nine MCs was 9.0 ± 1.4 days and for 23 PIVs, the 
average dwell time was 3.1 ± 0.5 days.  
 In 1999, Wyckoff reported on dwell times for 135 MCs placed in infants less than 30 
days old, ranging from 25 weeks to 46 weeks gestation, and ranging in weight from 540 grams to 
4010 grams.  The mean dwell time for these catheters was 10 days, with a range of one to 80 
days.  This data was compared to average PIV dwell times of approximately 27.5 to 49.5 hours.   
 In 2002, Dawson completed a retrospective chart review of 32 infants who received MCs. 
A unit protocol for this review included a requirement for MCs to be placed at the time of 
admission for all neonates expected to require a minimum of three days of IV therapy.  The 
gestational age of the infants who received MCs ranged from 24 to 42 weeks.  This data was 
compared to other infants of similar gestational age who received PIVs instead of MCs.  The 
findings revealed that the infants with PIVs experienced an average dwell time of eight days, 
with approximately nine venipuncture attempts per day.  The MC group of infants experienced 
an average dwell time of 6.3 days, with approximately 2.0 venipuncture attempts per day. 
 Leick-Rude and Haney (2006) conducted a prospective quality assurance monitoring 
review of 1,130 MCs placed in 858 infants of gestational ages 23 to 42 weeks, weighing 360-
8,000 grams.  The MCs were inserted when the infants were 23-61 days of age.  The scalp was 
the most frequently used site, with an average dwell time of 9.2-10 days.  MCs placed in the 
scalp were discontinued electively more than any other site, had the least number of infiltrations 
(17%), and 19% were removed for occlusion.  Upper extremity MCs were removed due to 
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infiltration 21% of the time and occlusion 12% of the time.  Average dwell time for upper 
extremity MCs was 8.1 days.   Lower extremity MCs were the least common site used.  Average 
dwell time for knee insertion was 12.9 days and for ankle insertion was 7 days.   
 Leick-Rude and Haney (2006) reported that 22% of the MCs were removed for 
infiltration, 17% for occlusion, 11% for leaking, 4% for dislodgement, 2% for phlebitis, and two 
MCs were removed for malposition based on clinical presentation. There were 39 blood cultures 
obtained from the infants while a MC was in place and 8 MCs were removed because of a 
positive blood culture.  Sixty-one percent of the infants with positive blood cultures also had a 
central line in place when the culture was drawn.  Of the infants with positive blood cultures, 
1.3% had only a MC. 
 Some authors suggest the feasibility of choosing a MC for a patient is based on an 
expected need for IV therapy greater than seven days (Goetz et al., 1998).  Griffiths (2007) 
reports that Vygon, a company which makes MCs, recommends that dwell times be based on the 
expected duration of treatment, rather than on a specified time scale.  The INS recommends 
consideration for MC placement in neonates when IV therapy is expected to last 1-4 weeks.  The 
NANN recognize that mean MC dwell times are typically reported to be between six to 10 days, 
but acknowledges the fact that current data does not exist to support a limit to the dwell time of 
properly functioning MCs. 
 Cost.  MC use in the NICU may result in cost savings associated with lower infection 
rates, less nursing time required due to fewer venipunctures, less pharmacy costs for antibiotics, 
and ultimately a shorter length of stay (Alexandrou et al., 2011; Dawson, 2002; Joanna Briggs 
Institute, 1998; Lesser et al., 1996; Rosenthal, 2008).  When compared to PIVs, MCs are 
typically more cost efficient in patients who meet criteria for placement (Anderson, 2004).  
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According to the NANN PICC Guidelines, the cost of a MC is equivalent to that of a PIV after 3-
4 days of therapy.  In patients who are clinically appropriate for home IV therapy, MCs are more 
cost effective than PICCs as a result of the ability to allow for an earlier discharge home 
(Griffiths, 2007).  In comparison to PICCs, MC placement may also result in cost savings as they 
do not require an X-ray to confirm the location of the catheter’s tip (Mermel et al., 1995; 
Wychoff, 1999).  
 Practice criteria.  MCs are recommended for solutions with a maximum dextrose 
concentration of 10% and isotonic solutions with a pH range of 5 to 9 (Alexandrou et al., 2011; 
Griffiths, 2007; Leick-Rude and Haney, 2006; NANN, 2007; Rosenthal, 2008).  The INS (2011) 
and NANN (2007) recommend infusion of fluid and medications with osmolalities <600 
mOsm/kg for MCs.  Examples of vesicants and hyperosmolar medications and IV fluids which 
are not considered safe for infusion through MCs include Total Parenteral Nutrition with 
dextrose concentration of D12.5% or greater, Amphoteracin B, Calcium, chemotherapy 
medications, Dilantin, vasopressors, and Vancomycin (NANN, 2007; Rosenthal, 2008).   
Summary 
 There are few studies evaluating MC outcomes, particularly in the pediatric and neonatal 
population (Anderson, 2004).  In comparison to the multitude of high level research available on 
PICCs, there is an absence of randomized control trials and systematic reviews evaluating MCs .  
Larger, prospective studies are needed to evaluate current MC practice in the NICU, and the 
rates of infection and extravasation associated with their use (Mermel et al., 1995; Victor, 1997).  
The INS (1997, 2011) recommends that institutions establish outcome data on specific patient 
populations for each VAD, and incorporate evidence based practice into current policies, 
procedures, and guidelines. Despite some literature describing observational data, midline 
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catheters are not an appropriate vascular access device for NICU patients due to insufficient high 
level evidence demonstrating safety and efficacy. 
Project Methodology 
 University of North Florida Institutional Review Board Attachment B for Protocol # 
558281-2 is included as Appendix B.  This document describes the Participant Population, Study 
Procedures and Materials, Risk/Benefit Analysis, and Data and Safety Monitoring, for the 
project entitled “Midline Catheter Use in the Newborn Intensive Care Unit: Current Practice 
Inquiry”. 
Results 
 A 22 question survey was available for 30 days (as allowed by NANN) on the NANN 
website for members to voluntarily complete.  The Survey Objectives are included as Appendix 
E.  NANN reports a membership of 7500 which includes neonatal nurses and Neonatal Nurse 
Practitioners.  The survey was created and the data was compiled via Qualtrics software.  Thirty 
six surveys were completed. 
Demographics 
 NICUs are designated as Level 1, 2, 3, or 4 depending on the level of care they are able to 
provide for neonates and infants.  Level 1 typically equates to a Newborn Nursery with healthy 
newborns, and Level 2 for clinically stable infants weighing greater than 1000 grams at birth. 
Level 3 NICUs provide most surgical and consultative services for critically ill infants.  Level 4 
NICUs additionally offer Extracorporeal Membrane Oxygenation, or ECMO, for the sickest of 
infants.  Seventy-six percent (28) of respondents completing the survey reported working in a 
Level 3 NICU.  
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 Eighty-six percent of participants reported that they work in a NICU and Figure 3 
describes participant level of nursing education.  The remaining 14% (5) reported their places of 
employment as the Newborn Nursery, the Pediatric Intensive Care Unit, and/or Newborn 
Transport Teams.    
 
           * Other = BSN, CNS, DNP  
Figure 3. Education 
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Procedure Guidelines, Protocols, and Training (Figures 4-8) 
                                                                                                                
specific MC Protocol in place for neonates and infants. 
 
 
 
 
 
 
Figure 4. Procedure Guidelines  
 
 
       
 
 
 
 
 
 
 
Figure 5. Procedure Protocols 
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Figure 6. PICC Training 
 
 
 
      
 
 
 
 
 
 
Figure 7. MC Training 
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Figure 8. VAD Competencies 
 
 
 
Participant Estimation of Successful VAD Placement and Usage (Figure 9)  
 
 
Figure 9. VAD Placement  
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 Of nineteen responses, the number of PICCs placed annually ranged from 6 to 1000, with 
an average of 272.  Of seventeen responses, the number of MCs placed annually ranged from 0 
to 500, with an average of 82.  Survey results from the questions asking about rates of infection 
and extravasation for VADs were tabulated incorrectly and are therefore not available for 
analysis. 
Knowledge and Beliefs (Figures 10 and 11) 
 
  
 
 
 
 
 
 
Figure 10. VAD Use      
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Figure 11. VAD Agreement 
 
Comments 
 
 Several participants submitted comments in the section provided at the end of the survey.  
The majority of the comments referred to their experience of using PICC lines as MCs when they 
are not centrally placed.  One respondent indicated that MCs are often considered a “default” 
when a centrally placed PICC is not obtained.  Another commented that “if a PICC becomes 
dislodged, it may be salvaged as a MC”.  Some mentioned that they do not use different MC 
devices and that these catheters are referred to as “peripheral PICCs”.  And finally, one 
participant reported that their unit is having difficulty in obtaining agreement among providers to 
use MCs due to lack of research. 
Discussion 
Findings 
 Demographics. The majority of respondents are Certified Neonatal Nurse Practitioners 
or Registered Nurses certified in Neonatal Intensive Care Nursing and reported working in Level 
3 NICUs located in urban areas. 
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 Procedure Guidelines, Protocols, and Training. Survey responses indicate that most 
NICUs have a VAD Team and follow National Guidelines for VAD insertion and maintenance.  
Interestingly, while most reported having a unit-specific PICC Protocol, the majority of 
responses also indicated the absence of a MC protocol.  More than half reported formal PICC 
training, but only one quarter of surveys indicated formal training as a requirement for placing 
MCs. In addition, while over half of the participants reported that they are required to complete 
competencies on a regular basis for PICCs, only 2 participants reported a requirement to 
complete MC competencies.  
 Participant Estimates of Successful VAD Placement and Usage.  Participants 
estimated personal success with VAD placement to be highest with PIV and PICC attempts, and 
lowest with MC attempts. Although the answers varied greatly, all participants indicated more 
PICCs are placed annually in their units, than MCs.   
 Knowledge and Beliefs.  Respondents were able to correctly identify the definitions for 
PICC and MC.  Of the 13 participants that responded to the questions pertaining to their beliefs 
about MC use, most indicated that no change is necessary, which suggests that they feel current 
MC use in their unit is appropriate.  However, the same participants also indicated that clinical 
providers often disagree about MC use.  In addition, the comments by participants point to a lack 
of consistency in regard to MC use in the NICU.   
Implications for Practice 
 In order to integrate high level clinical evidence into patient care, clinicians are 
challenged to synthesize mass quantities of published data, and incorporate these changes into 
daily practice.  Furthermore, institutional and national guidelines currently in place may not be 
evidence based, and some clinicians may be reluctant to practice differently if the evidence does 
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not coincide with tradition or clinician experience.  According to Black and Brennen (2011), 
successful implementation of practice change depends upon the ability to translate knowledge 
into practice, account for unit culture, manage change, encourage staff buy-in, incorporate a 
multidisciplinary approach, and utilize peer champions. 
 The only currently available national guideline for MC use in the neonatal population is 
NANN’s PICC Guidelines for Practice which currently lacks sufficient information for safe and 
effective use of MCs.  Neonatal nurses and Nurse Practitioners who rely on these guidelines for 
MC use may appreciate the need to improve upon them by individually evaluating this document 
using the AGREE II tool.  
 Multicenter, randomized control trials are needed to evaluate current MC practice in the 
NICU, and the rates of infection and extravasation associated with their use.  This data must be 
disseminated in such a way that provides clinicians with the evidence necessary to incorporate 
these changes into patient care on a daily basis.  
Conclusion 
 The results of this small, online survey indicate that while some neonatal nurses and 
Nurse Practitioners report the use of MC use in the NICU, few have MC-specific protocols in 
place.  In addition, few receive formal MC training and MC competencies are rarely required, 
which may explain participant estimation of less success with MC placement.  And finally, 
survey responses and comments indicate a lack of consistency in MC use and some disagreement 
among providers regarding appropriate use of this VAD.   
 Ongoing evaluation of current practice and incorporation of evidence based research into 
guidelines and protocols is a requirement for the provision of high quality, cost efficient care.  
MCs are not an appropriate VAD for NICU patients due to insufficient high level evidence 
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demonstrating safety and efficacy; thus, the continued use of this VAD may be called into 
question with regard to ethics, cost, and liability.  In summary, institutions must establish 
outcome data for MC use which is specific for neonates and infants, and incorporates current, 
evidence based practice into policies, procedures, and guidelines.   
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Appendix A: Midline Catheter Literature Review 
Table 1 
Midline Catheter Literature Review: Background and Discussion 
 
Author 
(Year) 
Lit 
Type 
Advantages Disadvantages Comments Recommendations 
Alexandrou et al. 
(2011) 
Lit Review  Fewer PIVs, 
Cost-effective, 
Potential to avoid 
infection, no XR 
confirmation necessary 
 Risk of extravasation 
can be high, not 
recommended for 
dextrose solution >10%, 
pH >5 and <9, most 
common complication is 
mechanical phlebitis 
 Not suitable for patients 
with history of thrombosis, 
hypercoagulopathy, or 
compromised venous 
circulation 
MC may be used in a variety of 
acute care setting where multiple 
peripheral cannulas traditionally 
have been used or as a 
replacement for a PICC 
or  CVC. 
 Anderson et al. 
(2004) 
Lit Review and 
program 
implementation 
process  
 In comparison to PIVs, 
fewer needle sticks, 
lower rates of 
infiltration and 
phlebitis, increased 
patient satisfaction, 
savings in nursing time 
and equipment costs 
 High rates of phlebitis 
and thrombosis with 
vesicant drugs 
 Few studies investigating 
MC outcomes 
 Use of a MC in place of a PIV 
comes at no extra operational 
costs to the hospital system, but 
offers a significant gain in 
positive outcomes. 
Colacchio et al. 
(2012)  
Retrospective 
Observational 
(PICC) 
   MCs not evaluated  MCs are different from 
PINCCs as they are shorter 
IV catheters, typically 
placed in the extremities 
with the tip purposefully 
meant to extend no further 
than the axillary vein or the 
inguinal fold. 
 MCs can be used both safely 
and effectively to provide stable 
IV access and to avoid many of 
the complications typically 
associated with central lines. 
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Author 
(Year) 
Lit 
Type 
Advantages Disadvantages Comments Recommendations 
Dawson (2002) Retrospective 
chart review 
(PIV) and 
program 
implementation 
(MC) 
Fewer venipunctures 
attempts; no mortality 
or morbidity factors 
associated with use; cost 
savings due to less 
nursing time, less 
pharmacy cost, and 
shorter length of stay; 
less handeling and 
longer periods of 
uninterrupted sleep 
which could result in 
improved weight gain 
and shorter length of 
stay 
Only acceptable for 
solutions safe for PIVs; 
average dwell time of 
6.3 days 
MCs placed on admission 
for all patients requiring 3+ 
days of IV therapy 
Use of MCs to deliver fluids in 
neonatal patients is appropriate 
 Griffiths (2007) Synopsis   Fewer PIVs, well 
tolerated by patients, 
may allow for earlier 
discharge, XR 
confirmation not 
typically required, ease 
of insertion, patient 
comport, ideal for 
patients with limited 
venous access, cost 
effective, acceptable for 
analgesia infusion 
 Not appropriate for 
Dextrose >10% or 
vesicants (such as 
antibiotics), does not 
accommodate >70 
mL/min, gravity infusion 
may not be possible, 
mechanical phlebitis, not 
applicable if venous 
anatomy is 
compromised, lack of 
trained personnel 
 Few studies available; 
institutional policy will 
dictate frequency of 
flushing; nursing procedure 
that requires medical order; 
dwell time may be for the 
duration of treatment rather 
than a specified time scale 
 MCs are a reliable VAD 
suitable for the safe delivery of 
IV drugs and fluids for patients 
who require medium to long-
term therapy. 
Moran (1992) Synopsis   FDA discontinued the 
use of Landmark 
Aquavene catheters in 
the 1990s for concerns 
for hypersensitivity 
reactions; mechanical 
phlebitis only reported in 
this study 
 Factors to consider when 
choosing a VAD – 
gestational age, weight, 
congenital anomalies, 
cardiorespiratory 
monitoring, sepsis, the 
number and frequency of 
caustic infusions, previous 
history of venous access 
devices, and the duration 
required 
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Author 
(Year) 
Lit 
Type 
Advantages Disadvantages Comments Recommendations 
Rosenthal (2008) Synopsis  Better hemodilution 
than PIVs; doesn’t 
require suturing; shorter 
hospital stay, improved 
patient satisfaction 
 Not appropriate for 
isotonic drugs/solutions, 
for infusion of 
continuous vesicants or 
irritants such as >10% 
Dextrose, parenteral 
nutrition, or for meds 
with high or low pH 
values like Vancomycin 
(2.4) or Dilantin (12); 
requires trained 
personnel; associated 
with insertion-related 
phlebitis 
   MCs are an effective tool to 
preserve a patient’s peripheral 
access and offer a cost-effective 
alternative to frequent IV site 
rotations. 
Victor (1997) Commentary Re: 
Lesser et al. 
(1996) 
 Provides 
developmentally 
appropriate and less 
stressful environment, 
may decrease the risk of 
iatrogenic complications 
from PIV 
    This study should be 
replicated with a larger 
sample size to validate the 
results 
MCs are a safe and effective 
method for delivering IV therapy 
for 1-2 weeks. 
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Table 2 
Midline Catheter Literature Review: Observational Studies 
 
Author 
(Year) 
Lit 
Type 
Advantages Disadvantages Comments Recommendations N = 
Goetz et al. 
(1998) 
Prospective 
Observational 
Fewer PIV starts, 
XR not required, 
cost savings, 
potential to 
preserve veins in 
patients with 
limited access, 
minimizes patient 
transfer in some 
institutions 
Potential for chemical 
and mechanical 
phlebitis, and 
obstruction 
Recommended for 
dwell times > 7d 
MCs can be used for 
prolonged IV therapy and 
are associated with 
infection rates comparable 
to PICC/CVL. MC is 
superior to PIV for 
patients with limited 
access who need extended 
IV therapy. 
- 248 patients 
- ages 23-98   
years 
- 334 MCs 
Leick-Rude & 
Haney (2006) 
Prospective 
Quality 
Assurance 
 Longer dwell 
times and fewer 
venipunctures 
than PIVs; fewer 
complications 
than PICCs; safe 
for antibiotics, 
Insulin, 
Prostaglandin, and 
blood transfusion 
products; may be 
used for 
antibiotics when 
sepsis is proven 
and PICC 
discontinued 
 Not appropriate for 
vesicant chemotherapy, 
parenteral nutrition, 
>10% dextrose or 5% 
protein, solutions or 
meds with pHs <5 or 
>9, or osmolality >500 
mOsm/liter; 34%-49% 
removal rate due to 
infiltration, leaking, or 
edema; not suitable for 
Vasopressors; not 
suitable to draw blood 
samples 
 Catheter duration by 
patient weight/ 
insertion site and 
reasons for catheter 
removal described in 
detail; PICC and MCs 
placed at time of 
umbilical catheter 
removal; care 
practices aimed at 
extending catheter 
dwell time require 
further investigation 
 MCs can be effectively 
and safely used for 
preterm and other high-
risk neonates to provide 
extended peripheral 
vascular access while 
avoiding many of the 
complications associated 
with central lines. 
- N not 
described 
- 23-42 weeks 
gestation 
- 1,130 MCs 
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Author 
(Year) 
Lit 
Type 
Advantages Disadvantages Comments Recommendations N = 
Lesser et al. 
(1996) 
Prospective 
Observational 
 PIVs lasted 3.1 
+/-1.5 days 
compared to 9.0 
+/- 1.4 for MCs; 
time and cost for 
CVCs and MCs 
are comparable 
but with fewer 
complications  
     MCs provide easy, safe, 
and prolonged intravenous 
access in low birth weight 
infants. 
- N not 
described 
- 25-34 weeks 
gestation 
- 9 MCs 
Mermel et al. 
(1995) 
Prospective 
Observational 
 Low risk for 
infection, reduce 
hospital and 
patient cost, XR 
not indicated 
   More prospective 
studies are needed to 
establish safety. 
 MCs fill an important 
niche in the care of acute 
and chronically ill patients. 
-130 patients  
- age not 
described 
- 140 MCs  
Wyckoff  (1999) Prospective 
Observational 
 External jugular, 
axillary, long and 
short saphenous, 
temporal, and 
posterior auricular 
veins are 
appropriate sites 
for consideration; 
MC dwell times 
have been 
reported to be 
almost 3x longer 
than PIVs; XR not 
typically required; 
may enable DC 
home for 
completion of IV 
therapy; decreased 
skin 
extravasation; 
decreased risk of 
infection, cost 
efficient 
    MCs appear to be a 
valuable alternative to 
PIVs in neonates requiring 
long-term IV access. 
- N not 
described 
- 25-46 weeks 
gestation 
- 143 MCs 
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Table 3 
Midline Catheter Literature Review: Policies and Procedures 
 
Author 
(Year) 
Lit 
Type 
Advantages Disadvantages Comments Recommendations 
Frey & Pettit 
(2010) 
INS textbook   Potential sites in 
neonates include 
antecubital, leg, and 
scalp 
 Infusate comparable to 
recs for PIVs, average 
dwell time in neonates is 
6-10 days, approximately 
50% of neonates MCs are 
removed due to comps 
with migration/infiltration 
 More studies are needed   
INS (1997)  Position Paper  In neonates, 
antecubital, external 
jugular, axillary, long 
and short saphenous, 
temporal, and 
posterior auricular 
veins may be 
considered 
 XR recommended if 
difficulty with 
advancement, pain or 
discomfort, no blood 
return, or if guidewire is 
bent after removal 
 No medical device is 
without risk, VAD 
assessment should lead to 
choosing the least 
invasive device 
Institutions must establish 
outcome data on their specific 
patient populations for each 
device and establish and revise 
policies and procedures based on 
the outcome data. 
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Author 
(Year) 
Lit 
Type 
Advantages Disadvantages Comments Recommendations 
INS (2011) Standards of 
Practice 
Appropriate for 
therapies anticipated 
to last 1-4 weeks; 
may be used for 
hydration, IV 
solutions, pain 
medications, and 
some antibiotics; 
catheter tip does not 
enter central 
vasculature; available 
as single or double 
lumen, polyurethane 
or silicone, and in 
gauge sizes of 22-24; 
additional insertion 
sites (leg,scalp) may 
be considered for 
neonates 
Reported dwell times for 
neonates is 6-10 days; not 
appropriate for vesicant 
therapy, parenteral 
nutrition, infusates with 
pH<5 or > 9, and infused 
with osmolality >600 
mOsm/L 
Tip location at or below 
the axillary line 
Indications and protocols for 
VADs shall be established in 
organizational policies, 
procedures, and/or practice 
guidelines and according to 
manufacturers’ directions for use. 
JBI Best 
Practice(2008)  
EBP Info Sheet        MCs appear to be associated with 
lower rates of phlebitis and 
infection than short peripheral 
catheters and cost less than 
central venous catheters. 
NANN (2007) Guidelines  Dwell times reported 
to be between 6-10 
days and up to four 
times as long as PIVs; 
fewer PIV restarts and 
longer lifespan; cost 
of MC equivalent to 
3-4 days of PIV 
Not appropriate for 
dextrose >10%, parenteral 
nutrition, Ampicillin, 
Cefotaxime, Sodium 
Bicarbonate, and 
Phenobarbital, or 
osmolality 
>600mOsm/kg, not 
appropriate for vesicants 
such as Amphoteracin B, 
Vasopressin, resuscitation 
meds, Dopamine, or 
Calcium 
No data exist to support 
dwell time limits 
MCs offer an alternative for those 
infants who do not require a 
PICC, but who need several days 
of IV therapy. 
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Appendix B: AGREE II Author Score Sheet of NANN PICC Guidelines for Practice 
 
Domain Item AGREE II Rating 
  1 
Strongly 
Disagree 
2 3 4 5 6 
7 
Strongly 
Agree 
Scope and 
purpose 
 
1. The overall objective(s) of the guideline is (are) specifically described.     X   
 2. The health question(s) covered by the guideline is (are) specifically described.   X     
 3. The population (patients, public, etc.) to whom the guideline is meant to apply is 
specifically described. 
 X      
Stakeholder 
involvement 
4. The guideline development group includes individuals from all the relevant 
professional groups. 
      X 
 5. The views and preferences of the target population (patients, public, etc.) have 
been sought. 
   X    
 6. The target users of the guideline are clearly defined.      X  
Rigor of 
development 
7. Systematic methods were used to search for evidence. X       
 8. The criteria for selecting the evidence are clearly described.  X      
 9. The strengths and limitations of the body of evidence are clearly described.  X      
 10. The methods for formulating the recommendations are clearly described. X       
 11. The health benefits, side effects and risks have been considered in formulating 
the recommendations. 
      X 
 12. There is an explicit link between the recommendations and the supporting 
evidence. 
  X     
 13. The guideline has been externally reviewed by experts prior to its publication.  X      
 14. A procedure for updating the guideline is provided. X       
Clarity of 15. The recommendations are specific and unambiguous.    X    
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Domain Item AGREE II Rating 
  1 
Strongly 
Disagree 
2 3 4 5 6 
7 
Strongly 
Agree 
presentation 
 16. The different options for management of the condition or health issue are 
clearly presented. 
 X      
 17. Key recommendations are easily identifiable.    X    
Applicability 18. The guideline describes facilitators and barriers to its application. X       
 19. The guideline provides advice and/or tools on how the recommendations can 
be put into practice. 
   X    
 20. The potential resource implications of applying the recommendations have 
been considered. 
X       
 21. The guideline presents monitoring and/ or auditing criteria. X       
Editorial 
independence 
22. The views of the funding body have not influenced the content of the guideline.       X 
 23. Competing interests of guideline development group members have been 
recorded and addressed. 
      X 
Overall 
Guideline 
Assessment 
1. Rate the overall quality of this guideline. 
    X    
Overall 
Guideline 
Assessment 
2. I would recommend this guideline for use. Yes Yes, with modifications No 
                                        X  
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Appendix C: Permission for Figure Reprint 
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INSTRUCTIONS: Please do not reply to this message. The Terms and Conditions of Use and the associated permission 
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insert the following language in the body of the message: I agree to the attached Terms and Conditions of Use. 
 
Please note that permission is withheld pending receipt by the BD Permissions Processing Group of your 
response accepting the attached Terms and Conditions of Use. 
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Last Name:   Romesberg 
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Describe in detail the material(s) for which you request permission to reprint: (e.g., include a) the full title, author and 
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For what duration will the material(s) be used?   for publication 
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 37 
Appendix D: UNF IRB # 558281-2 Attachment B 
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Appendix E: Survey Objectives 
MC Use in the NICU: Current Practice Inquiry 
1. Are MCs being used in NICUs across the US?  And if so, where and how frequently? 
2. Are the MCs being used, truly MCs by definition? 
3. What level of nurses are placing MCs? 
4. What type of training is required for nursing and NNPs to place MCs? 
5. What are individual nurse and NNP success rates for MC and PICC insertions? 
6. Do NICUs follow NANN and/or institutional protocols for PICCs and MCs? 
7. What are the rates of infection, extravasation, and phlebitis associated with VADs in 
NICUs? 
8. What are the individual and institutional preferences for the use of MCs in NICU 
patients? 
9. Do nurses and NNPs have an understanding of the available literature and 
recommendations regarding evidence based practice for MC use in the NICU? 
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Appendix F: National Association of Neonatal Nurses Online Survey 
Midline Catheter Use in the Newborn Intensive Care Unit: Current Practice Inquiry 
 
Q1 Dear National Association of Neonatal Nurses (NANN) and National Association of 
Neonatal Nurse Practitioner (NANNP) Members:  My name is Tricia Romesberg.  I am a 
doctoral student conducting a survey for my Doctor of Nursing Practice (DNP) Project at the 
University of North Florida (UNF) in Jacksonville, Florida.   I am requesting your assistance to 
help me understand midline catheter use in the Newborn Intensive Care Unit (NICU).  Your 
participation is important because survey results could add to the body of knowledge regarding 
current vascular access device practices for NICU patients.     To be included in the sample for 
the survey, you must be a NANN and/or NANNP member. This survey will take approximately 
10 minutes to complete. Qualtrics, the survey software, is designed to insure that all data will be 
submitted anonymously.  I will not have access to your identity at any time. To insure further 
data security, data submitted will be stored on a locked and secure computer.   Your participation 
is voluntary. While there are no anticipated risks involved in completing and submitting the 
survey, if you start the survey and then decide not to complete it, you may simply log out of 
Qualtrics and no data will be submitted or saved. Participation and completion of the survey will 
acknowledge your consent.  Participation is limited to those who are at least 18 years of 
age.  The survey will be available for participation during a one month period between May 2014 
and September 2014.  Please print a copy of this document for your records.     This study has 
received the approval of Institutional Review Board at the University of North Florida, IRB # 
558281, which functions to insure the protection of the rights of human participants.  If you have 
any questions about being a research participant, you may contact the UNF Institutional Review 
Board at  or via email at irb@unf.edu. Approval to post this survey on MyNANN 
was granted by the NANN Research Institute.      You may contact me via email at 
 or by phone at   I would like to thank you in 
advance for your participation in this survey.    Respectfully,     Tricia Romesberg, MSN, ARNP  
University of North Florida DNP Student     Dr. Carol Ledbetter, PhD, APRN-BC, FAAN  
University of North Florida DNP Project Chair       By 
clicking the “next” button, you agree to participate in this survey. 
 
Q2 What type of geographic area do you work in? 
 rural 
 urban 
 metropolitan 
 
Q3 If you work in a Newborn Intensive Care Unit, what is the level of acuity? 
 Level 1 
 Level 2 
 Level 3 
 Other: ____________________ 
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Q4 How many total months and years have you worked in the Newborn Intensive Care Unit as a 
nurse and/or Nurse Practitioner? 
 months 
 years 
 
Q5 Do you care for infants in a setting other than the Newborn Intensive Care Unit?: 
 No 
 Yes - please describe: ____________________ 
 
Q6 What is your level of education specific to caring for neonates and infants? Check all that 
apply: 
 registered nurse 
 Registered Nurse Certified (RNC) for Neonatal Intensive Care Nursing 
 Certified Neonatal Nurse Practitioner 
 Other: ____________________ 
 
Q7 Have you been trained to place Peripherally Inserted Central Catheters?  If yes, check all that 
apply: 
 At a formal training seminar 
 As a procedural requirement for your job 
 Informally by another nurse or nurse practitioner 
 Self taught or no training 
 Other: ____________________ 
 
Q8 Are you required by your unit or institution to complete competencies on  a regular basis to 
place Peripherally Inserted Central Catheters? 
 Yes 
 No 
 
Answer If Are you required by your unit or institution to complete competencies on a regular 
basis to place Peripherally Inserted Central Catheters? Yes Is Selected 
Q9 If yes, how often are Peripherally Inserted Central Catheter competencies required? Every: 
______ months 
______ years 
 
Q10 Have you been trained to place Midline Catheters?  If yes, check all that apply: 
 At a formal training seminar 
 As a procedural requirement for you job 
 Informally by another nurse or nurse practitioner 
 Self taught or no training 
 Other: ____________________ 
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Q11 Are you required by your unit or institution to complete competencies on a regular basis to 
place Midline Catheters? 
 Yes 
 No 
 
Answer If Are you required by your unit or institution to complete competencies on a regular 
basis to place Midline Catheters? Yes Is Selected 
Q12 If yes, how often are Midline Catheter competencies required? Every: 
______ months 
______ years 
 
Q13 Please answer yes or no: 
   
 Yes No 
Does your unit have a 
vascular access or 
Peripherally Inserted Central 
Catheter Team? 
    
Does your unit adhere to 
NANN's 2007 Peripherally 
Inserted Central Catheter 
Guidelines for Practice? 
    
Does your unit have a unit-
specific Peripherally Inserted 
Central Catheter Protocol for 
neonates and infants? 
    
Does your unit have a unit-
specific Midline Catheter 
Protocol for neonates and 
infants? 
    
 
 
Q14 At your current place of employment, please estimate percentages of the following: 
 Click to write Column 1 Click to write Column 2 Click to write Column 3 
 Infection Extravasation Phlebitis 
Peripheral IVs    
Midline Catheters    
Peripherally Inserted 
Central Catheters 
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Q15 In your best estimate, how many Peripherally Inserted Central Catheters are placed annually 
in your unit? 
   ____________________ 
 How many are placed by you? ____________________ 
 
Q16 In your best estimate, how many Midline Catheters are placed annually in your unit? 
   ____________________ 
 How many are placed by you? ____________________ 
 
Q17 Please rate your personal success in achieving insertion and proper placement of the 
following vascular access devices: 
 Peripheral IV Midline Catheter Peripherally Inserted 
Central Catheter 
Never       
Rarely       
Sometimes       
Often       
All of the Time       
 
 
Q18 Based on your clinical experience with Midline Catheters in the unit you currently work in, 
it is your opinion that Midline Catheters should be used:______  
 
Q19 Disagreement about Midline Catheter use among the clinical providers in you unit occurs: 
______  
 
Q20 The definition of a Peripherally Inserted Central Catheter is: "a device inserted into a 
peripheral vein and threaded into the central venous circulation." 
 True 
 False 
 
Q21 The definition of a Midline Catheter is: "a peripheral vascular access device with the tip 
terminating in the basilic, cephalic, or brachial vein." 
 True 
 False 
 
Q22 Midline Catheter use in neonates and infants is supported by high level evidence such as 
systematic reviews and/or randomized clinical trials. 
 True 
 False 
 
Q23 Comments on your experiences with Midline Catheter use in neonates and infants? 
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